Skip to main content
Erschienen in: Reactions Weekly 1/2011

01.11.2011 | Case report

Fluorouracil

Beriberi with encephalopathy, vegetative instability, lactic acidosis and neuropathy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Rosen A, Van Kuilenburg A, Assmann B, Kuhlen M, Borkhardt A.Severe encephalopathy, lactic acidosis, vegetative instability and neuropathy with 5-fluorouracil treatment - Pyrimidine degradation defect or beriberi?. Case Reports in Oncology 4: 371-376, No. 2, Aug 2011. Available from: URL: http://dx.doi.org/10.1159/000328803 - Germany Rosen A, Van Kuilenburg A, Assmann B, Kuhlen M, Borkhardt A.Severe encephalopathy, lactic acidosis, vegetative instability and neuropathy with 5-fluorouracil treatment - Pyrimidine degradation defect or beriberi?. Case Reports in Oncology 4: 371-376, No. 2, Aug 2011. Available from: URL: http://​dx.​doi.​org/​10.​1159/​000328803 - Germany
Metadaten
Titel
Fluorouracil
Beriberi with encephalopathy, vegetative instability, lactic acidosis and neuropathy: case report
Publikationsdatum
01.11.2011
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2011
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201113760-00046

Weitere Artikel der Ausgabe 1/2011

Reactions Weekly 1/2011 Zur Ausgabe

Case report

Iobenguane

Case report

Hydroxocobalamin

Case report

Cotrimoxazole